Two lots of the over-the-counter antacid drug Tums are being recalled due to the possibility of contamination with metal fragments, according to a notice published by CVS Pharmacy last week.
CVS Pharmacy said that multiple lots of Tums Ultra Assorted Fruit Chewable Tablet bottles are being recalled on a voluntary basis “due to potential contamination with small metal pieces.”
“Customers who purchased recalled product should immediately discontinue use of it. A full refund can be obtained by returning product purchased at CVS Pharmacy to a nearby store,” said the notice, which was dated May 27.
The notice added that the product under recall includes two lots of Tums Ultra Assorted Fruit Chewable Tablets in 1000-milligram strength, with a count of 160 tablets. One lot under recall has the lot number of 1096078 and an expiration date of Jan. 31, 2029, while the other lot has the same expiration date and a lot number of 1096076.
An Epoch Times review shows that the notice has not been published to the Food and Drug Administration’s recall database.
It’s not clear whether other retailers that sell the affected Tums products have publicly announced a recall. Also unclear is how many packages of the Tums product are being recalled or if any adverse events were reported in connection with the action.
Haleon—which also manufactures common over-the-counter medications and products, including Advil, Sensodyne, Excedrin, Benfiber, Centrum, Gas-X and Flonase—initiated the recall, according to the CVS notice. Based in the United Kingdom, Haleon was established in 2022 as a corporate spin-off company of GSK.
Tums is among the most popular over-the-counter antacid medications used to relieve acid indigestion, an upset stomach, heartburn, or related symptoms. The product, carried by a number of major retailers around the United States and online, has calcium carbonate as its active ingredient.
Last week, more than 285,000 blister packs of Gas-X were recalled by Haleon’s U.S. division due to the product having incomplete inactive ingredient information on the outer carton, according to a notice published by the FDA. The health agency classified the recall as Class II, which means it could produce “temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
It comes as a research company last month released a report finding that U.S. product recalls increased 27 percent in the first three months of 2026, on a quarter-over-quarter basis. The number of units that were recalled in the first quarter of the year rose to 492 million, according to Sedgwick’s quarterly Product Safety and Recall Index report.
Haleon did not immediately respond to an Epoch Times request for comment on Monday.